Senti Biosciences
Focus: Senti Biosciences is a gene circuit and cell & gene therapy company focused on respiratory, infectious disease, and oncology indications. The company operates as a pre-revenue biotech with an early-stage pipeline.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at Senti Biosciences?
AI assessmentHigh-risk, high-upside opportunity best suited for scientists/engineers seeking early-stage innovation exposure, not stability-focused candidates.
Why Work Here
- Cutting-edge platform in gene circuits and cell & gene therapy—emerging modalities with significant long-term market potential
- Diversified pipeline spanning respiratory, oncology, and infectious disease with multiple clinical programs active
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Senti V1.0 Device
Respiratory DiseaseClinical Trials (1)
NCT04693091Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology
N/AHelp build intelligence for Senti Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.